{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T06:34:38Z","timestamp":1794724478529,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T00:00:00Z","timestamp":1579478400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T00:00:00Z","timestamp":1579478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The national burden of human immunodeficiency virus treatment failure and associated factors in the Ethiopian context is required to provide evidence towards a renewed ambitious future goal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We accessed Ethiopian Universities\u2019 online repository library, Google Scholar, PubMed, Web of Science, and Scopus to get the research articles. We run I-squared statistics to see heterogeneity. Publication bias was checked by using Egger\u2019s regression test. The pooled prevalence was estimated using the DerSimonian-Laird random-effects model. We employed the sensitivity analysis to see the presence of outlier result in the included studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The overall human immunodeficiency treatment failure was 15.9% (95% confidence interval: 11.6\u201320.1%). Using immunological, virological, and clinical definition, human immunodeficiency treatment failure was 10.2% (95% confidence interval: 6.9\u201313.6%), 5.6% (95% confidence interval: 2.9\u20138.3%), and 6.3% (95% confidence interval: 4.6\u20138.0%), respectively. The pooled effects of World Health Organization clinical stage III\/IV (Adjusted Odd Ratio\u2009=\u20091.9; 95% CI: 1.3\u20132.6), presence of opportunistic infections (Adjusted Odd Ratio\u2009=\u20091.8; 95% CI: 1.2\u20132.4), and poor adherence to highly active antiretroviral therapy (Adjusted Odd Ratio\u00a0=\u20098.1; 95% CI: 4.3\u201311.8) on HIV treatment failure were estimated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Human immunodeficiency virus treatment failure in Ethiopia found to be high. Being on advanced clinical stage, presence of opportunistic infections, and poor adherence to highly active antiretroviral therapy were the contributing factors of human immunodeficiency virus treatment failure. Human immunodeficiency virus intervention programs need to address the specified contributing factors of human immunodeficiency virus treatment failure. Behavioral intervention to prevent treatment interruption is required to sustain human immunodeficiency virus treatment adherence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Protocol registration<\/jats:title>\n                    <jats:p>It has been registered in the PROSPERO database with a registration number of CRD42018100254.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-020-8160-8","type":"journal-article","created":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T09:05:05Z","timestamp":1579511105000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["HIV\/AIDS treatment failure and associated factors in Ethiopia: meta-analysis"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9121-6549","authenticated-orcid":false,"given":"Aklilu","family":"Endalamaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengistu","family":"Mekonnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demeke","family":"Geremew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fikadu Ambaw","family":"Yehualashet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiwot","family":"Tesera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tesfa Dejenie","family":"Habtewold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,20]]},"reference":[{"key":"8160_CR1","unstructured":"World Health Organization. Global Health Observatory (GHO) data: Summary of the global HIV epidemic. 2019. https:\/\/www.who.int\/gho\/hiv\/en\/. Accessed Dec 2019."},{"key":"8160_CR2","unstructured":"UNAIDS. Country\/Ethiopia Overview. 2019. https:\/\/www.unaids.org\/en\/regionscountries\/countries\/ethiopia. Accessed Dec 2019."},{"issue":"1","key":"8160_CR3","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1186\/s12889-019-7885-8","volume":"19","author":"M Adal","year":"2019","unstructured":"Adal M. Systematic review on HIV situation in Addis Ababa, Ethiopia. BMC Public Health. 2019;19(1):1544.","journal-title":"BMC Public Health"},{"issue":"Suppl 3","key":"8160_CR4","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1097\/01.aids.0000327510.68503.e8","volume":"22","author":"TC Quinn","year":"2008","unstructured":"Quinn TC. HIV epidemiology and the effects of antiviral therapy on long-term consequences. AIDS (London, England). 2008;22(Suppl 3):S7.","journal-title":"AIDS (London, England)"},{"issue":"4","key":"8160_CR5","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1016\/j.jfda.2013.09.043","volume":"21","author":"MW Hull","year":"2013","unstructured":"Hull MW, Montaner JS. HIV treatment as prevention: the key to an AIDS-free generation. J Food Drug Anal. 2013;21(4):S95\u2013S101.","journal-title":"J Food Drug Anal"},{"issue":"4","key":"8160_CR6","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/COH.0b013e32833a6c32","volume":"5","author":"R Granich","year":"2010","unstructured":"Granich R, Crowley S, Vitoria M, Smyth C, Kahn JG, Bennett R, et al. Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update. Curr Opin HIV AIDS. 2010;5(4):298.","journal-title":"Curr Opin HIV AIDS"},{"key":"8160_CR7","unstructured":"World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: World Health Organization; 2013."},{"issue":"1","key":"8160_CR8","doi-asserted-by":"publisher","first-page":"21133","DOI":"10.7448\/IAS.19.1.21133","volume":"19","author":"M Sidib\u00e9","year":"2016","unstructured":"Sidib\u00e9 M, Loures L, Samb B. The UNAIDS 90\u201390\u201390 target: a clear choice for ending AIDS and for sustainable health and development. J Int AIDS Soc. 2016;19(1):21133.","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"8160_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2015-000010","volume":"1","author":"J Levi","year":"2016","unstructured":"Levi J, Raymond A, Pozniak A, Vernazza P, Kohler P, Hill A. Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades. BMJ Glob Health. 2016;1(2):e000010.","journal-title":"BMJ Glob Health"},{"key":"8160_CR10","unstructured":"Zoungrana J et al. Prevalence and Factors Associated with Treatment Failure during Antiretroviral Therapy Atbobo-Dioulasso University Teaching Hospital (Burkina Faso) (2008\u20132013). Austin J HIV\/AIDS Res. 2016;3(2):1027."},{"issue":"Suppl 2","key":"8160_CR11","doi-asserted-by":"publisher","first-page":"A9-A","DOI":"10.1136\/bmjgh-2016-000260.20","volume":"2","author":"M Owusu","year":"2017","unstructured":"Owusu M, Mensah E, Enimil A, Mutocheluh M. Prevalence and risk factors of virological failure among children on antiretroviral therapy. BMJ Global Health. 2017;2(Suppl 2):A9-A.","journal-title":"BMJ Global Health"},{"issue":"7","key":"8160_CR12","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1093\/jac\/dkw051","volume":"71","author":"C Hawkins","year":"2016","unstructured":"Hawkins C, Ulenga N, Liu E, Aboud S, Mugusi F, Chalamilla G, et al. HIV virological failure and drug resistance in a cohort of Tanzanian HIV-infected adults. J Antimicrob Chemother. 2016;71(7):1966\u201374.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"8160_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126026","volume":"10","author":"YT Yimer","year":"2015","unstructured":"Yimer YT, Yalew AW. Magnitude and predictors of anti-retroviral treatment (ART) failure in private health facilities in Addis Ababa, Ethiopia. PLoS One. 2015;10(5):e0126026.","journal-title":"PLoS One"},{"issue":"5","key":"8160_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196259","volume":"13","author":"GG Hailu","year":"2018","unstructured":"Hailu GG, Hagos DG, Hagos AK, Wasihun AG, Dejene TA. Virological and immunological failure of HAART and associated risk factors among adults and adolescents in the Tigray region of northern Ethiopia. PLoS One. 2018;13(5):e0196259.","journal-title":"PLoS One"},{"issue":"4","key":"8160_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-019181","volume":"8","author":"MM Sisay","year":"2018","unstructured":"Sisay MM, Ayele TA, Gelaw YA, Tsegaye AT, Gelaye KA, Melak MF. Incidence and risk factors of first-line antiretroviral treatment failure among human immunodeficiency virus-infected children in Amhara regional state, Ethiopia: a retrospective follow-up study. BMJ Open. 2018;8(4):e019181.","journal-title":"BMJ Open"},{"key":"8160_CR16","unstructured":"Yayehirad AM, Mamo WT, Gizachew AT, Tadesse AA. Rate of immunological failure and its predictors among patients on highly active antiretroviral therapy at Debremarkos hospital, Northwest Ethiopia: a retrospective follow up study. J AIDS Clinical Res 2013;4(5)."},{"issue":"12","key":"8160_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012537","volume":"6","author":"AT Tsegaye","year":"2016","unstructured":"Tsegaye AT, Wubshet M, Awoke T, Alene KA. Predictors of treatment failure on second-line antiretroviral therapy among adults in Northwest Ethiopia: a multicentre retrospective follow-up study. BMJ Open. 2016;6(12):e012537.","journal-title":"BMJ Open"},{"issue":"1","key":"8160_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.296","volume":"5","author":"S Yassin","year":"2017","unstructured":"Yassin S, Gebretekle GB. Magnitude and predictors of antiretroviral treatment failure among HIV-infected children in fiche and Kuyu hospitals, Oromia region, Ethiopia: a retrospective cohort study. Pharmacol Res Perspect. 2017;5(1):e00296.","journal-title":"Pharmacol Res Perspect"},{"issue":"7","key":"8160_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000100","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.","journal-title":"PLoS Med"},{"key":"8160_CR20","volume-title":"The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis","author":"GA Wells","year":"2011","unstructured":"Wells GA, Shea, B., O'Connell, D., Peterson, J., Welch, V., et al,. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis 2011."},{"issue":"12","key":"8160_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115125","volume":"9","author":"W Teshome","year":"2014","unstructured":"Teshome W, Assefa A. Predictors of immunological failure of antiretroviral therapy among HIV infected patients in Ethiopia: a matched case-control study. PLoS One. 2014;9(12):e115125.","journal-title":"PLoS One"},{"issue":"1","key":"8160_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/1471-2334-12-197","volume":"12","author":"T Bacha","year":"2012","unstructured":"Bacha T, Tilahun B, Worku A. Predictors of treatment failure and time to detection and switching in HIV-infected Ethiopian children receiving first line anti-retroviral therapy. BMC Infect Dis. 2012;12(1):197.","journal-title":"BMC Infect Dis"},{"issue":"749","key":"8160_CR23","first-page":"2","volume":"8","author":"C Sisay","year":"2017","unstructured":"Sisay C, Bekele A, Sisay A, Mekonen H, Terfa K. Incidence and predictors of anti-retroviral treatment (ART) failure among adults receiving HIV Care at Zewditu Memorial Hospital, Addis Ababa, Ethiopia. J AIDS Clin Res. 2017;8(749):2.","journal-title":"J AIDS Clin Res"},{"issue":"224\u20133208","key":"8160_CR24","first-page":"1","volume":"4","author":"Y Getnet","year":"2014","unstructured":"Getnet Y. Determinants of first line antiretroviral treatment failure in public hospitals of Addis Ababa, Ethiopia: unmatched case control study. J Biol Agriculture Healthcare. 2014;4(224\u20133208):1\u201312.","journal-title":"J Biol Agriculture Healthcare"},{"issue":"1","key":"8160_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/1471-2334-14-181","volume":"14","author":"A Abdissa","year":"2014","unstructured":"Abdissa A, Yilma D, Fonager J, Audelin AM, Christensen LH, Olsen MF, et al. Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia. BMC Infect Dis. 2014;14(1):181.","journal-title":"BMC Infect Dis"},{"key":"8160_CR26","doi-asserted-by":"crossref","unstructured":"Workneh N, Girma T, Woldie M. Immunologic and clinical outcomes of children on HAART: a Retrospective cohort analysis at Jimma University specialized hospital. Ethiop J Health Sci. 2009;19(2).","DOI":"10.4314\/ejhs.v19i2.69422"},{"issue":"2","key":"8160_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-013528","volume":"7","author":"BT Tadesse","year":"2017","unstructured":"Tadesse BT, Foster BA, Jerene D, Ruff A. Cohort profile: improving treatment of HIV-infected Ethiopian children through better detection of treatment failure in southern Ethiopia. BMJ Open. 2017;7(2):e013528.","journal-title":"BMJ Open"},{"issue":"11","key":"8160_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187694","volume":"12","author":"YD Babo","year":"2017","unstructured":"Babo YD, Alemie GA, Fentaye FW. Predictors of first-line antiretroviral therapy failure amongst HIV-infected adult clients at Woldia hospital. Northeast Ethiopia PloS one. 2017;12(11):e0187694.","journal-title":"Northeast Ethiopia PloS one"},{"key":"8160_CR29","first-page":"153","volume":"9","author":"B Bayu","year":"2017","unstructured":"Bayu B, Tariku A, Bulti AB, Habitu YA, Derso T, Teshome DF. Determinants of virological failure among patients on highly active antiretroviral therapy in University of Gondar Referral Hospital, Northwest Ethiopia: a case-control study. HIV\/AIDS (Auckland, NZ). 2017;9:153\u20139.","journal-title":"HIV\/AIDS (Auckland, NZ)"},{"key":"8160_CR30","unstructured":"Bokretsion GB, Endalkachew N, Getachew KA. HIV\/AIDS treatment failure and its determinant factors among first line HAART patients at Felege-Hiwot Referral Hospital, Bahir Dar, Northwest Ethiopia. J AIDS Clin Res. 2017;8(11):2-8."},{"issue":"11","key":"8160_CR31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.5897\/IJMMS2015.1164","volume":"8","author":"A Zeleke","year":"2016","unstructured":"Zeleke A. Prevalence of antiretroviral treatment failure and associated factors in HIV infected children on antiretroviral therapy at Gondar University hospital, retrospective cohort study. Int J Med Med Sci. 2016;8(11):125\u201332.","journal-title":"Int J Med Med Sci"},{"key":"8160_CR32","first-page":"141","volume":"8","author":"MB Ayalew","year":"2016","unstructured":"Ayalew MB, Kumilachew D, Belay A, Getu S, Teju D, Endale D, et al. First-line antiretroviral treatment failure and associated factors in HIV patients at the University of Gondar Teaching Hospital, Gondar, Northwest Ethiopia. HIV\/AIDS (Auckland, NZ). 2016;8:141.","journal-title":"HIV\/AIDS (Auckland, NZ)"},{"issue":"1","key":"8160_CR33","doi-asserted-by":"publisher","first-page":"20637","DOI":"10.7448\/IAS.19.1.20637","volume":"19","author":"D Nash","year":"2016","unstructured":"Nash D, Tymejczyk O, Gadisa T, Kulkarni SG, Hoffman S, Yigzaw M, et al. Factors associated with initiation of antiretroviral therapy in the advanced stages of HIV infection in six Ethiopian HIV clinics, 2012 to 2013. J Int AIDS Soc. 2016;19(1):20637.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"8160_CR34","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1186\/s12913-018-3347-8","volume":"18","author":"A Deribew","year":"2018","unstructured":"Deribew A, Biadgilign S, Berhanu D, Defar A, Deribe K, Tekle E, et al. Capacity of health facilities for diagnosis and treatment of HIV\/AIDS in Ethiopia. BMC Health Serv Res. 2018;18(1):535.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"8160_CR35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4314\/ejhs.v27i1.6S","volume":"27","author":"A Haileamlak","year":"2017","unstructured":"Haileamlak A, Hagos T, Abebe W, Abraham L, Asefa H, Teklu AM. Predictors of hospitalization among children on ART in Ethiopia: a cohort study. Ethiop J Health Sci. 2017;27(1):53\u201362.","journal-title":"Ethiop J Health Sci"},{"key":"8160_CR36","doi-asserted-by":"crossref","unstructured":"Gebremichael DY, Hadush KT, Kebede EM, Zegeye RT. Food insecurity, nutritional status, and factors associated with malnutrition among people living with HIV\/AIDS attending antiretroviral therapy at public health facilities in west Shewa zone, Central Ethiopia. Biomed Res Int. 2018;2018.","DOI":"10.1155\/2018\/1913534"},{"issue":"2","key":"8160_CR37","first-page":"107","volume":"50","author":"S Abdissa","year":"2012","unstructured":"Abdissa S, Fekade D, Feleke Y, Seboxa T, Diro E. Adverse drug reactions associated with antiretroviral treatment among adult Ethiopian patients in a tertiary hospital. Ethiop Med J. 2012;50(2):107\u201313.","journal-title":"Ethiop Med J"},{"key":"8160_CR38","unstructured":"Selamawit Z, Nurilign A. Common mental disorder among HIV infected individuals at Comprehensive HIV Care and Treatment Clinic of Debre Markos referral Hospital, Ethiopia. J AIDS Clin Res. 2015;6(2)."},{"key":"8160_CR39","doi-asserted-by":"crossref","unstructured":"Amare T, Getinet W, Shumet S, Asrat B. Prevalence and associated factors of depression among PLHIV in Ethiopia: systematic review and meta-analysis, 2017. AIDS Res Treatment. 2018;2018.","DOI":"10.1155\/2018\/5462959"},{"issue":"9","key":"8160_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182688","volume":"12","author":"NK Le","year":"2017","unstructured":"Le NK, Riggi E, Marrone G, Van Vu T, Izurieta RO, Nguyen CKT, et al. Assessment of WHO criteria for identifying ART treatment failure in Vietnam from 2007 to 2011. PLoS One. 2017;12(9):e0182688.","journal-title":"PLoS One"},{"issue":"3","key":"8160_CR41","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1093\/cid\/cis433","volume":"55","author":"BP Westley","year":"2012","unstructured":"Westley BP, DeLong AK, Tray CS, Sophearin D, Dufort EM, Nerrienet E, et al. Prediction of treatment failure using 2010 World Health Organization guidelines is associated with high misclassification rates and drug resistance among HIV-infected Cambodian children. Clin Infect Dis. 2012;55(3):432\u201340.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"8160_CR42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1742-6405-8-42","volume":"8","author":"N Khienprasit","year":"2011","unstructured":"Khienprasit N, Chaiwarith R, Sirisanthana T, Supparatpinyo K. Incidence and risk factors of antiretroviral treatment failure in treatment-na\u00efve HIV-infected patients at Chiang Mai University Hospital, Thailand. AIDS Res Ther. 2011;8(1):42.","journal-title":"AIDS Res Ther"},{"key":"8160_CR43","doi-asserted-by":"crossref","unstructured":"Soria A, Porten K, Fampou-Toundji J, Galli L, Mougnutou R, Buard V, et al. Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients. Antivir Ther. 2009;14(3):339-47.","DOI":"10.1177\/135965350901400317"},{"issue":"1","key":"8160_CR44","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/imr.12066","volume":"254","author":"AA Okoye","year":"2013","unstructured":"Okoye AA, Picker LJ. CD 4+ T-cell depletion in HIV infection: mechanisms of immunological failure. Immunol Rev. 2013;254(1):54\u201364.","journal-title":"Immunol Rev"},{"issue":"8","key":"8160_CR45","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1007\/s10461-018-2152-z","volume":"22","author":"Aklilu Endalamaw","year":"2018","unstructured":"Endalamaw A, Tezera N, Eshetie S, Ambachew S, Habtewold TD. Adherence to highly active antiretroviral therapy among children in Ethiopia: a systematic review and meta-analysis. AIDS Behav. 2018;22(8):2513\u201323.","journal-title":"AIDS and Behavior"},{"issue":"3","key":"8160_CR46","first-page":"187","volume":"48","author":"A Giday","year":"2010","unstructured":"Giday A, Shiferaw W. Factors affecting adherence of antiretroviral treatment among AIDS patients in an Ethiopian tertiary university teaching hospital. Ethiop Med J. 2010;48(3):187\u201394.","journal-title":"Ethiop Med J"},{"issue":"2","key":"8160_CR47","first-page":"174","volume":"22","author":"E Markos","year":"2008","unstructured":"Markos E, Worku A, Davey G. Adherence to ART in PLWHA and Yirgalem hospital, South Ethiopia. Ethiop J Health Dev. 2008;22(2):174\u20139.","journal-title":"Ethiop J Health Dev"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-8160-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-020-8160-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-8160-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T20:47:51Z","timestamp":1665521271000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-020-8160-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,20]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["8160"],"URL":"https:\/\/doi.org\/10.1186\/s12889-020-8160-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.16879\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.16879\/v2","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,20]]},"assertion":[{"value":"24 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable because no primary data were collected.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}